Literature DB >> 3792332

Proteoglycan synthesis by fibroblast cultures initiated from regions of adult bovine tendon subjected to different mechanical forces.

K G Vogel, E J Keller, R J Lenhoff, K Campbell, T J Koob.   

Abstract

Fibroblast cultures were initiated from two distinct regions of the adult bovine deep flexor tendon and synthesis of 35S-labeled proteoglycans by these cultures was investigated. The proximal/tensional region of the tendon was composed of linearly arranged dense collagen bundles, and its glycosaminoglycan hexosamine content was only 0.2% of the dry weight of the tissue. The proteoglycans of this region were predominantly small (Kav = 0.5 on Sepharose CL-4B). Cells placed into culture from this region attached to the substratum readily, and the radiolabeled proteoglycans from these cultures were 90% small proteoglycans. In a more distal region of the tendon that is subjected to compressive forces, the collagen was arranged as a network of fibrils separated from each other by a matrix that stained intensely with Alcian blue. The glycosaminoglycan content of this compressed region was up to 5-fold higher than in the proximal region, and as much as 50% of the proteoglycans were large molecules (eluted from Sepharose CL-4B in the Vo). Cells placed into culture from the distal/compressed region did not attach to the substratum as readily as those from the proximal region and were characterized by the presence of numerous cytoplasmic lipid inclusions. The [35S]proteoglycans synthesized by the distal tendon fibroblast cultures were divided into two approximately equal populations of large and small proteoglycans having elution characteristics similar to the proteoglycans extracted from this tissue. The distinct profiles of proteoglycan production were maintained by the cells in culture for several weeks, although eventually the amount of large proteoglycan synthesized by the distal tendon fibroblast cultures diminished. Both regions of tendon contained predominantly type I collagen, and collagen production was about 10% of the total protein synthesized by both cell cultures. These observations indicate that adult tendon fibroblasts in culture express stable synthesis of proteoglycan populations similar to those found in the region of tendon from which they were derived.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792332

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  7 in total

1.  Catabolism of aggrecan, decorin and biglycan in tendon.

Authors:  S G Rees; C R Flannery; C B Little; C E Hughes; B Caterson; C M Dent
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Proteoglycan synthesis in organ cultures from regions of bovine tendon subjected to different mechanical forces.

Authors:  T J Koob; K G Vogel
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

Review 3.  Activity vs. rest in the treatment of bone, soft tissue and joint injuries.

Authors:  J A Buckwalter
Journal:  Iowa Orthop J       Date:  1995

4.  Optical anisotropy of a pig tendon under compression.

Authors:  VeraLúciaC Feitosa; Benedicto C Vidal; Edson R Pimentel
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

5.  Flexor Tendon Injury and Repair. The Influence of Synovial Environment on the Early Healing Response in a Canine Model.

Authors:  Hua Shen; Susumu Yoneda; Shelly E Sakiyama-Elbert; Qiang Zhang; Stavros Thomopoulos; Richard H Gelberman
Journal:  J Bone Joint Surg Am       Date:  2021-05-05       Impact factor: 6.558

6.  Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen.

Authors:  W B Stallcup; K Dahlin; P Healy
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems.

Authors:  Sarah E Taylor; Anne Vaughan-Thomas; Dylan N Clements; Gina Pinchbeck; Lisa C Macrory; Roger K W Smith; Peter D Clegg
Journal:  BMC Musculoskelet Disord       Date:  2009-02-26       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.